Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Merck reportedly eyeing acquisition of Seattle biotech giant Seagen
05:45pm, Friday, 17'th Jun 2022
Biopharma giant Merck is considering an acquisition of Seagen, the Seattle area's biggest biotech company, according to a report in the Wall Street Journal Friday.
Why Seagen Surged Today
03:26pm, Friday, 17'th Jun 2022
Merck is thinking about whether it's an appealing acquisition target.
Seagen Shares Pop on Rumors of Merck Acquisition
03:07pm, Friday, 17'th Jun 2022
Shares of Seagen Inc. ( SGEN , Financial) climbed more than 16% to about $170 on Friday as investors piled into the stock on rumors the company was being eyed by Merck & Co. Inc. ( MRK , Financial). A
SGEN Stock Alert: Is Merck About to Buy Seagen?
02:48pm, Friday, 17'th Jun 2022
Today, various reports have highlighted a potential deal for Merck to buy out Seagen, taking SGEN stock on a nice ride this afternoon. The post SGEN Stock Alert: Is Merck About to Buy Seagen?
Merck Shows Takeover Interest In Seagen: WSJ
11:27am, Friday, 17'th Jun 2022
Merck & Co Inc (NYSE: MRK) is reportedly mulling buying cancer-focused biotech Seagen Inc (NASDAQ: SGEN), Wall Street Journal reported citing people familiar with the matter. If the deal happens,
Merck considering purchase of cancer drug maker Seagen - WSJ
11:16am, Friday, 17'th Jun 2022
Drugmaker Merck & Co is considering buying cancer-focused biotech company Seagen Inc, the Wall Street Journal reported on Friday, citing people familiar with the matter.
Seagen's stock surges after WSJ reports $31 billion-valued biotech is being eyed by Merck
11:03am, Friday, 17'th Jun 2022
Shares of Seagen Inc. SGEN, +12.02% shot up 14.7% toward a seven-month high in morning trading Friday, after The Wall Street Journal reported that Merck & Co. Inc. MRK, -0.02% is looking into buying t
10 Biggest Price Target Changes For Monday
11:45am, Monday, 06'th Jun 2022 Benzinga
Citigroup cut PVH Corp. (NYSE: PVH) price target from $94 to $73. PVH shares fell 0.7% to close at $71.96 on Friday.
Piper Sandler reduced JOANN Inc. (NASDAQ: JOAN) price target from $11 to $6. JO
Ligand (LGND) Down 4.9% Since Last Earnings Report: Can It Rebound?
03:31pm, Friday, 03'rd Jun 2022 Zacks Investment Research
Ligand (LGND) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Axsome (AXSM) Down 30.3% Since Last Earnings Report?
03:50pm, Wednesday, 01'st Jun 2022 Zacks Investment Research
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Growth Stocks to Buy Now
04:44pm, Friday, 27'th May 2022
EPS estimates are generally a strong indication of future growth. That's just one part of finding reliable growth stocks.
Seagen (SGEN) Posts Positive Data from New Study on Tukysa
02:58pm, Tuesday, 24'th May 2022 Zacks Investment Research
Seagen (SGEN) reports favorable data on the pivotal phase II MOUNTAINEER study evaluating Tukysa in combination with Herceptin for treating HER2-positive metastatic colorectal cancer.
Seagen (SGEN) Posts Positive Data from New Study on Tukysa
12:03pm, Tuesday, 24'th May 2022
Seagen (SGEN) reports favorable data on the pivotal phase II MOUNTAINEER study evaluating Tukysa in combination with Herceptin for treating HER2-positive metastatic colorectal cancer.
Seagen's (SGEN) Stock Up on CEO's Resignation Announcement
03:31pm, Tuesday, 17'th May 2022 Zacks Investment Research
Seagen's (SGEN) current chief executive officer and president, Clay Siegall, announces his resignation. The company is looking for a new CEO. Stock up.
Seagen's (SGEN) Stock Up on CEO's Resignation Announcement
12:47pm, Tuesday, 17'th May 2022
Seagen's (SGEN) current chief executive officer and president, Clay Siegall, announces his resignation. The company is looking for a new CEO.
